Biotech Values

[DewDiligence]

IDYA IPOs 5.75M* shares @$10.00:

https://www.prnewswire.com/news-releases/ideaya-announces-pricing-of-initial-public-offering-300855642.html

IDEAYA [Biosciences] is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the targeted therapies IDEAYA is developing. IDEAYA is applying these capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality – which represents an emerging class of precision medicine targets.

*Assuming exercise of underwriter’s option.